Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Assembly Biosciences (NQ: ASMB )

2.190 +0.090 (+4.29%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 1, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 218,047
Open 2.120
Bid (Size) 2.140 (10)
Ask (Size) 2.210 (75)
Prev. Close 2.100
Today's Range 2.060 - 2.205
52wk Range 1.320 - 3.940
Shares Outstanding 48,216,473
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
7 Penny Stocks That Could Triple in 2022
Penny stocks are affordable and some with credible business models in all likelihood have the potential to generate superior returns. 
Via InvestorPlace
Assembly Bio Commences Early-Stage Study of Drug to Treat Hepatitis B Viral Infection
Assembly Biosciences, Inc. (NASDAQ: ASMB) today announced Initiation of Phase 1b clinical study of its drug candidate ABI-H3733 for Chronic Hepatitis B Virus Infection 
Via Benzinga

Performance

YTD
-10.61%
-10.61%
1 Month
+17.11%
+17.11%
3 Month
+6.31%
+6.31%
6 Month
-6.01%
-6.01%
1 Year
-42.67%
-42.67%

More News

Read More
The Daily Biotech Pulse: Third FDA Rejection For Verrica's Skin Disease Drug, Assembly Bio Terminates Hepatitis B Virus Pact, Consistency Data For Valneva's Chikungunya Vaccine
Via Benzinga
Week In Review: I-Mab Files For Hong Kong SPAC IPO To Acquire Life Science Company
Via Talk Markets
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Mid-Afternoon Market Update: Dow Rises 90 Points; Kirkland's Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures US Equities
Benzinga's Top Ratings Upgrades, Downgrades For September 13, 2021
Via Benzinga
Dow Up Triple Digits, Poised to Snap Three-Day Skid
Via Talk Markets
Topics Stocks
Exposures US Equities
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Mid-Day Market Update: Crude Oil Jumps Over 2%; Assembly Biosciences Shares Plunge
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
65 Biggest Movers From Yesterday
Via Benzinga
Mid-Morning Market Update: Markets Open Higher; Hormel Foods Cuts Earnings Outlook
Via Benzinga
Topics Stocks
Exposures US Equities
46 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 2, 2021
Via Benzinga
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
Via Benzinga
Exposures COVID-19 Product Safety
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
28 Stocks Moving in Thursday's Pre-Market Session
Via Benzinga
Assembly Bio Stock Tumbles On Discontinuation Of Hepatitis B Trial
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
10 Stocks Moving In Wednesday's After-Hours Session
Via Benzinga
The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street
Via Benzinga
The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study
Via Benzinga
Topics Stocks
Exposures US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.